UpToDate Talk

Guselkumab and tildrakizumab for plaque psoriasis; Two new investigational therapies for hemophilia

10.04.2017 - By UpToDatePlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

This episode features Dr. Kristina Callis Duffin discussing the efficacy and safety of guselkumab and tildrakizumab in patients with moderate to severe plaque psoriasis, and Dr. Amy Shapiro discussing emicizumab prophylaxis in hemophilia A with inhibitors and targeting of antithrombin in hemophilia A or B using RNA interference therapy. Dr. Jennifer Tirnauer hosts.

More episodes from UpToDate Talk